For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Transient cerebral ischemia - Independent medicine & health information for consumers & professionals Transient cerebral ischemia
Show health professional infoLatest independent information about transient cerebral ischemia, including medicines and non-drug treatments, written and reviewed by experts in Australia.
Transient cerebral ischemia is also known as stroke, cerebrovascular accident, CVA, mini stroke, transient ischemic attack or TIA.
| Filter by audience: | |
|---|---|
| All | |
| Consumer | |
| Health professional | |
| Researchers & evaluators | |
| Members & stakeholders | |
| Other | |
| Title | Description | Type | Audience  |
Date* |
|---|---|---|---|---|
Statins remain important for people at high risk of heart attack or stroke |
NPS is urging people taking statins to continue to take their medicine as prescribed and to see their doctor if they are unsure about the benefit of the medicine for them. |
Media release | Others | 2012-03-01 19:00:00 |
Case study 29 report: Warfarin therapy |
Elderly patient presents with INR of 4.6 (normally stable between 2.0-3.0). On warfarin for 12 months following a suspected TIA and has atrial fibrillation. |
Professional activity - Case study report | Health Professionals | 2003-12-01 00:00:00 |
Case study 29: Warfarin therapy |
Elderly patient presents with INR of 4.6 (normally stable between 2.0-3.0). On warfarin for 12 months following a suspected TIA and has atrial fibrillation. |
Professional activity - Case study | Health Professionals | 2003-10-01 00:00:00 |
Case study 56 report: Antithrombotic options in stroke prevention |
Anne is a 75-year-old retired professional who is very worried because she is currently experiencing some fatigue and palpitations. |
Professional activity - Case study | Health Professionals | 2009-05-15 00:00:00 |
Case study 56: Antithrombotic options in stroke prevention |
Anne is a 75-year-old retired professional who is very worried because she is currently experiencing some fatigue and palpitations. |
Professional activity - Case study | Health Professionals | 2009-02-01 00:00:00 |
Case study PH8 report: For pharmacists. Warfarin therapy |
Elderly patient reports an INR of 4.6 (normally stable between 2.0-3.0). On warfarin for 12 months following a suspected TIA and has atrial fibrillation. |
Professional activity - Case study report | Health Professionals | 2004-01-01 00:00:00 |
Case study PH8: For Pharmacists. Warfarin therapy |
Elderly patient reports an INR of 4.6 (normally stable between 2.0-3.0). On warfarin for 12 months following a suspected TIA and has atrial fibrillation. |
Professional activity - Case study | Health Professionals | 2003-10-01 00:00:00 |
Complications of type 1 diabetes - Independent medicine & health information |
People with type 1 diabetes may develop complications, especially if blood glucose isn’t controlled. Smoking, having high blood pressure or high cholesterol, or heavy alcohol intake may cause complications sooner. Common complications include eye conditions, kidney disease, heart disease, stroke, nerve problems & feet problems. |
Web page | Consumers,Others,Research & Evaluation community | 2011-12-06 00:00:00 |
Complications of type 2 diabetes - Independent medicine & health information |
People with type 2 diabetes may develop complications, especially if blood glucose isn’t controlled. Smoking, having high blood pressure or high cholesterol, or heavy alcohol intake may cause complications sooner. Common complications include eye conditions, kidney disease, heart disease, stroke, nerve problems & feet problems. |
Web page | Consumers,Others,Research & Evaluation community | 2011-11-14 00:00:00 |
Dabigatran (Pradaxa): NPS RADAR Review |
The latest issue of NPS RADAR provides an independent review of dabigatran (Pradaxa), an oral anticoagulant, for preventing stroke or systemic embolism in people with non-valvular atrial fibrillaton. In Australia, dabigatran is currently only available on private prescription for this indication. Dabigatran is currently PBS listed for short-term prophylaxis of venous thromboembolism after hip or knee replacement surgery |
Media release | Others | 2011-08-02 19:00:00 |
Diclofenac and cardiovascular risk |
Fact sheet reviewing the evidence for vascular risk associated diclofenac and other NSAIDs. |
Professional publication - NPS factsheet | Health Professionals | 2006-09-15 00:00:00 |
Diclofenac and cardiovascular risk |
Fact sheet reviewing the evidence for vascular risk associated diclofenac and other NSAIDs. |
Media factsheet | Health Professionals,Others | 2006-09-15 00:00:00 |
Heart and stroke: what's your risk score? |
Asking your doctor to calculate your ‘heart and stroke risk score’ can be the first step to preventing cardiovascular disease. |
Consumer publication - MedicinesTalk | Consumers | 2011-09-05 00:00:00 |
Independent review of new stroke prevention medicine helps people Be medicinewise |
Dabigatran (Pradaxa) – a new anticoagulant medicine to help prevent strokes in people with an irregular heartbeat (atrial fibrillation) is reviewed in the latest edition of Medicine Update, an online newsletter published by NPS: Better choices, Better health. |
Media release | Others | 2011-08-09 19:00:00 |
Keep taking your statins: benefits outweigh risks |
Recent media reports suggest statin medicines increase the risk of diabetes & memory loss in patients. However, research shows that the benefits of statins outweigh the risks & NPS is advising people to keep taking their statin medicines, unless their doctor says otherwise. Read more on the risks & benefits of statins here |
Web page | Consumers | 2012-03-01 00:00:00 |
Managing my heart health |
Download a Managing my heart health at a glance card. This card helps people with or at risk of cardiovacular disease to track their medical and lifestyle factors, including medicine compliance and daily activity. |
Consumer publication - Brochure | Consumers,Health Professionals | 2011-09-16 00:00:00 |
Dabigatran (Pradaxa) for preventing stroke in people with atrial fibrillation |
This Medicine Update is about using dabigatran to prevent stroke in people with a condition called atrial fibrillation. Dabigatran can also be used after hip or knee replacement surgery (see the April 2010 Medicine Update issue). |
Consumer publication - Medicine Update | Consumers | 2011-08-05 00:00:00 |
New information on Varenicline (Champix) inconclusive: NPS (for consumers) |
New research linking an anti-smoking medicine to an increased risk of heart attacks remains uncertain. Anyone with concerns about taking the medicine should talk to their health professional or seek more information, according to NPS MedicineWise |
Media release | Others | 2011-07-20 19:00:00 |
New information on Varenicline (Champix) inconclusive: NPS (health professionals) |
Uncertainty remains despite new research published this month linking a smoking-cessation medicine to an increased risk of heart attacks, according to NPS |
Media release | Others | 2011-07-20 19:00:00 |
Atrial fibrillation and warfarin management |
Analysis of aspirin and warfarin in reducing thromboembolic risk in atrial fibrillation. Includes interactions with herbal medicines. Case study on warfarin. |
Professional publication - NPS News | Health Professionals | 2003-10-01 00:00:00 |
Stroke prevention - Role of antithrombotics |
Outlines use of antithrombotic (antiplatelet and anticoagulant) therapies in preventing ischaemic stroke and tools for communicating risks and benefits to patients. |
Professional publication - NPS News | Health Professionals | 2009-02-02 00:00:00 |
Stroke prevention - Antiplatelets and anticoagulants |
Use of antithrombotic (antiplatelet and anticoagulant) therapies in the long-term prevention of ischaemic stroke and provides tools for communicating risks and benefits to patients. |
Professional publication - Prescribing Practice Review | Health Professionals | 2009-03-02 00:00:00 |
Pharmacy Practice Review – reducing cardiovascular disease risk |
Pharmacy Practice Review - Reducing cardiovascular disease (CVD) risk is part of the 2011 NPS therapeutic program on CVD risk and guiding lipid management for health professionals and builds on the NPS vision to encourage quality use of medicines |
Media release | Others | 2011-06-07 19:00:00 |
Prevent stroke by using optimal antithrombotic therapy |
The National Prescribing Service Limited (NPS) is advising health professionals to consider aspirin for primary stroke prevention in those at high cardiovascular risk, to prevent recurrent stroke by using antiplatelet therapy and to use warfarin in those with atrial fibrillation at higher risk of stroke. |
Media release | Others,Health Professionals | 2009-02-19 19:00:00 |
Supporting outreach pharmacists across Australia |
Outreach pharmacists who provide valuable pharmacy services to remote Aboriginal Health Services are invited to participate in a new education program on stroke prevention run by the National Prescribing Service Limited (NPS). |
Media release | Others | 2009-10-13 19:00:00 |
Switching patients from Vioxx |
Fact sheet providing general advice about switching patients from rofecoxib (Vioxx) after its withdrawal due to an increased risk of cardiovascular events associated with use. |
Professional publication - NPS factsheet | Health Professionals | 2004-10-07 00:00:00 |
What are the benefits for me? Preventing stroke with warfarin |
How someone decided whether to take warfarin for stroke prevention. |
Consumer resource - Story | Consumers | 2011-01-24 00:00:00 |
What health professionals can do on World Stroke Day |
What health professionals can do on World Stroke Day |
Media release | Others | 2009-10-29 19:00:00 |
Your heart and stroke risk score patient resource |
The Your heart and stroke risk score summary sheet explains absolute cardiovascular risk to patients and includes a space for you to record their risk score. |
Professional tool - Patient leaflet | Health Professionals | 2011-09-21 00:00:00 |
Information on this website is published by NPS — an independent, evidence based, not-for-profit organisation funded by the Australian Government Department of Health and Ageing.
NPS develops its information under the guidance of experts in their field, editorial panels, expert reviewers and consumers. Find out more about how we develop our content.
Date published: 2010-12-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
